Clearstead Trust’s Protolabs PRLB Stock Holding History

Clearstead Trust’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16	Closed	-$801	–	1407
2025 Q3	$801	Hold	16	–	–	﹤0.01%	1281
2025 Q2	$641	Buy	+16	New	+$596	﹤0.01%	1277

Other funds holding PRLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Clearstead Trust's PRLB Position: Q4 2025 in Review

Clearstead Trust sold out of Protolabs (PRLB) in Q4 2025, closing a stake of 16 shares — an estimated $801 sold.

Clearstead Trust first reported a position in PRLB in Q2 2025 and held it in 2 quarters. The position peaked at $801 in Q3 2025. 234 funds tracked by Wall St. Rank hold PRLB as of Q4 2025.

Clearstead Trust reported no remaining Protolabs position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 16 Protolabs shares in Q4 2025, an estimated $801.
Clearstead Trust first reported a position in Protolabs in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Protolabs position peaked at $801 in Q3 2025.
234 funds tracked by Wall St. Rank held Protolabs as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.